홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Betahistine Hydrochloride

HCID 68643
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
5579-84-0
표준 SMILES
CNCCc1ccccn1.Cl.Cl
InChIKey
XVDFMHARQUBJRE-UHFFFAOYSA-N
분자식
C8H14Cl2N2
평균 분자량
209.11 g/mol
단동위원소 질량
208.0534038

개요

Betahistine Hydrochloride is the hydrochloride salt form of betahistine, a histamine analog with weak histamine H1 agonistic and more potent histamine H3 antagonistic properties. Upon intranasal administration, betahistine binds to histamine H1 and H3 receptors and exerts its agonistic and antagonistic actions locally and centrally. This promotes cochlear, vestibular and cerebral blood flow, decreases neuronal firing in the vestibular nuclei and increases histamine synthesis and release in the brain which facilitates vestibular compensation. Increased blood flow around the inner ear reduces the amount of fluid in the inner ear and may alleviate vertigo, tinnitus, and hearing loss.

이름 및 식별자

우선 이름
Betahistine Hydrochloride
IUPAC
N-methyl-2-pyridin-2-ylethanamine;dihydrochloride
영어명
Betahistine dihydrochloride
분자식
C8H14Cl2N2
분자량
209.12

이름 및 동의어

Betahistine hydrochlorideBetahistine HClSercBetaserc2-Pyridineethanamine, N-methyl-, dihydrochloride2-(2-(Methylamino)ethyl)pyridine dihydrochloride49K58SMZ7UNSC-757397DTXSID102043552-[2-(Methylamino)ethyl]pyridine dihydrochlorideSerc-8Serc-16
이름 더 보기
Betahistine Di HClPT-9SinMenierBetahistineHClBETASTINE DI HCLBetahistine 2 hcl
RefChem:567992DTXCID10126846226-966-5Betahistine dihydrochloride5579-84-0Betahistine 2HClMicroserAntivom

데이터베이스 식별자

CAS
5579-84-0
PubChem CID
68643
DTXSID
DTXSID10204355
ChEMBL
CHEMBL1446813
UNII
49K58SMZ7U
EC Number
226-966-5

물성

구조 계산 물성

극성 표면적
24.9 Ų
수소 결합 공여자 수
3
수소 결합 수용자 수
2
회전 가능 결합 수
3
무거운 원자 수
12
형식 전하
0
복잡도
83.3

물리화학적 성질

녹는점
150 · 150-154 °C
저장 조건
2 · 2-8°C
용해도
물에 매우 잘 녹고, 에탄올(96%)에 잘 녹으며, 2프로판올에는 거의 녹지 않습니다.
물리적 상태
가루
색상
옅은 노랑
안정성
흡습성
InChI
InChI=1S/C8H12N2.2ClH/c1-9-7-5-8-4-2-3-6-10-8;;/h2-4,6,9H,5,7H2,1H3;2*1H
InChIKey
XVDFMHARQUBJRE-UHFFFAOYSA-N
SMILES
C1(CCNC)=NC=CC=C1.Cl.Cl

화학적 성질

white to light yellow crystalline powder

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 5건

This chemical does not meet GHS hazard criteria for 1.8% (1 of 55) of reports.

Warning

H315 (94.5%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 55 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Other Safety InformationIMAP assessments - 2-Pyridineethanamine, N-methyl-, dihydrochloride: Environment tier I assessment
Hazard Classes and CategoriesSkin Irrit. 2 (94.5%)

안전 데이터

wgk
3
rtecs
UT2969000
HS 번호
29333990
safety_code
24/25
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

MeSH Pharmacological Classification · 2건

Drugs used to cause dilation of the blood vessels.

Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically.

응용 분야 · 3건

개요Betahistine dihydrochloride (BH.2HCl) is an orally active histamine analog which has been used to control vertigo, lack of hearing and tinnitus related to Ménière’s disease. The mechanism of BH.2HCl is to reduce the pressure of the membranous labyrinth that results in enhancement of the microvasculature circulation and improves the signs of Ménière’s disease. Peroral administration undergoes extensive first-pass metabolism and gastric irritation in patients with peptic ulcer. In treatment of vertigo, a uniform and constant supply of drug is required in order to maintain steady-state concentration of the drug in the body. Unfortunately, BH.2HCl possesses a short half-life of about 3–4 h and requires frequent administration of the drug,12–15 thereby making it an ideal candidate for controlled release preparations.

용도Betahistine is belongs to a group of medications used to treat vertigo associated with Ménière's disease. Vertigo is a condition that causes sufferers to have a sensation of rotation or movement of themselves or their surroundings. Ménière's disease is a disorder of the inner ear that causes vertigo in addition to symptoms such as ringing in the ears, headache, and loss of hearing.Betahistine is used to reduce the number of episodes of vertigo associated with Ménière's disease. It is believed to work by decreasing the pressure in the ear. This pressure is believed to contribute to the sense of dizziness, nausea, and ringing in the ears and hearing loss that people with Ménière's disease experience.

일반 설명Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

상·하류 제품 정보

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트

하류 제품

N-Methyl-N,N-bis(2-pyridylethyl)amine